Support of existing NHSBT owned Extracorporial Photopheresis Systems

NHS Blood and Transplant (NHSBT)contractContracts FinderRef CF-2762300D0O000000rwimUAASME suitablecomplete
View buyer

Estimated value

£5.2m

Awarded value

£8.0m

Awarded 18 Dec 2024

Suppliers

1

Lots

1

1 awarded

Published

19 Dec 2024

Deadline 19 Dec 2024

Description

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box. The contract award is for maintenance, training and consumables to support existing Therakos CellEx Extracorporeal Photopheresis machine platforms. This Contract is for a period of 2 years with one 12-month option to extend.

Scope

Reference
CF-2762300D0O000000rwimUAA
Total value
£5,173,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
01 Feb 2025 to 31 Jan 2028
CPV classifications
33140000 50420000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
19 Dec 2024, 12:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£8.0m

Award date

18 Dec 2024

Contract start

01 Feb 2025

Contract end

31 Jan 2028

Awarded to